EGLT Egalet Corporation

5.03
+0.03  (0.6%)
Previous Close 5.00
Open 5.00
Price To book 4.82
Market Cap 123.81M
Shares 24,614,000
Volume 308,899
Short Ratio 5.85
Av. Daily Volume 871,577

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

sNDA filed December 1, 2016.
OXAYDO
Acute and chronic moderate to severe pain
Phase 3 to be completed 4Q 2017. NDA planned for 2018.
Egalet-002
Moderate to severe chronic pain
Approved January 9, 2017.
Egalet-001 (ARYMO ER)
Abuse-Deterrent Morphine

Latest News

  1. SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Egalet Corporation (EGLT) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
  2. IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm
  3. EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Egalet Corporation – EGLT
  4. EQUITY ALERT: Lundin Law PC Announces an Investigation of Egalet Corporation and Encourages Investors with Losses to Contact the Firm
  5. SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Egalet Corporation (EGLT) & Lead Plaintiff Deadline: March 28, 2017
  6. IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm
  7. EGLT INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017
  8. INVESTOR ALERT: Lundin Law PC Announces an Investigation of Egalet Corporation and Encourages Investors with Losses to Contact the Firm
  9. IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm
  10. SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline: March 28, 2017
  11. SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Egalet Corporation and Encourages Investors with Losses to Contact the Firm
  12. SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Egalet Corporation and Certain Officers – EGLT
  13. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Has Filed a Complaint to Recover Losses Suffered by Investors in Egalet Corporation
  14. IMPORTANT EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm
  15. EGLT LOSS NOTICE: Rosen Law Firm Reminds Egalet Corporation Investors of Important Deadline in Class Action – EGLT
  16. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Egalet Corporation To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
  17. SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Egalet Corporation (EGLT) and Lead Plaintiff Deadline: March 28, 2017
  18. Levi & Korsinsky Files in U.S. District Court to Recover Losses Suffered by Investors in Egalet (EGLT)
  19. IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Egalet Corporation and Encourages Investors with Losses to Contact the Firm
  20. EGLT SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Egalet Corporation and a Lead Plaintiff Deadline of March 28, 2017